Stay updated on Entinostat Combo in RCC Clinical Trial
Sign up to get notified when there's something new on the Entinostat Combo in RCC Clinical Trial page.
Latest updates to the Entinostat Combo in RCC Clinical Trial page
- Check4 days agoChange DetectedThe study has transitioned to a terminated status, with the funder halting development of the compound for metastatic renal cell carcinoma, while new results have been posted detailing the Phase II study's design and treatment protocols.SummaryDifference23%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check32 days agoNo Change Detected
- Check47 days agoChange DetectedThe study has been updated to version v2.10.0, with two locations now included, replacing the previous version v2.9.7.SummaryDifference0.3%
- Check54 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check68 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check73 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content related to the study details of a Phase II clinical trial evaluating the safety, pharmacodynamics, and efficacy of Entinostat in combination with Nivolumab and Ipilimumab for patients with metastatic renal cell carcinoma.SummaryDifference0.1%
Stay in the know with updates to Entinostat Combo in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entinostat Combo in RCC Clinical Trial page.